Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Mouth Neoplasms 1Melanoma 1Lymphoid Interstitial Pneumonia 1Lymphedema 1Head and Neck Neoplasms 1Fibrosis 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cetuximab 3Gemcitabine 2Gefitinib 2Biopsy 2vandetanib 1temsirolimus 1ficlatuzumab 1cediranib 1X-Rays 1Soybean Proteins 1Sirolimus 1Rhinoplasty 1Restraint, Physical 1Radiotherapy, Intensity-Modulated 1Pilocarpine 1Pemetrexed 1Paclitaxel 1Optical Imaging 1Nivolumab 1Methods 1Metformin 1Lenalidomide 1Ipilimumab 1Independent Medical Evaluation 1Immunohistochemistry 1Educational Status 1Carboplatin 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Lymphoid Interstitial Pneumonia × Independent Medical Evaluation × Clear all
NCT01816841 2020-01-30

Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental Care

Ohio State University Comprehensive Cancer Center

Phase NA Completed
68 enrolled
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡